CASI Pharmaceuticals Inc. (CASI)
(Delayed Data from NSDQ)
$6.59 USD
+0.05 (0.76%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $6.52 -0.07 (-1.06%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.62 |
EPS Last Quarter | -0.52 |
Last EPS Surprise | 17.46% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.56 |
Next Year | -2.13 |
EPS (TTM) | -1.87 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.56M | 7.39M | 19.80M | 46.48M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 4.56M | 7.39M | 19.80M | 46.48M |
Low Estimate | 4.56M | 7.39M | 19.80M | 46.48M |
Year ago Sales | 8.84M | 6.03M | 33.04M | 19.80M |
Year over Year Growth Est. | -48.42% | 22.55% | -40.07% | 134.75% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.62 | -0.60 | -2.56 | -2.13 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.62 | -0.60 | -2.56 | -2.13 |
High Estimate | -0.62 | -0.60 | -2.56 | -2.13 |
Low Estimate | -0.62 | -0.60 | -2.56 | -2.13 |
Year ago EPS | -0.35 | -0.29 | -1.86 | -2.56 |
Year over Year Growth Est. | -77.14% | -106.90% | -37.63% | 16.80% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.62 | -0.60 | -2.56 | -2.13 |
7 Days Ago | -0.62 | -0.60 | -2.56 | -2.13 |
30 Days Ago | -0.62 | -0.60 | -2.56 | -2.13 |
60 Days Ago | -0.62 | -0.60 | -2.56 | -2.13 |
90 Days Ago | -0.62 | -0.60 | -2.56 | -2.13 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.62 | -0.60 | -2.56 | -2.13 |
Zacks Consensus Estimate | -0.62 | -0.60 | -2.56 | -2.13 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.52 | -0.71 | -0.29 | -0.35 | NA |
Estimate | -0.63 | -0.05 | -0.24 | -0.56 | NA |
Difference | 0.11 | -0.66 | -0.05 | 0.21 | -0.10 |
Surprise | 17.46% | -1,320.00% | -20.83% | 37.50% | -321.47% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more